A method for improving the properties of famotidine.
Aqueous solubility
Crystal structure
Famotidine
M-nitrobenzoic acid
Permeability
Journal
Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
received:
03
06
2023
revised:
16
06
2023
accepted:
20
06
2023
medline:
7
7
2023
pubmed:
7
7
2023
entrez:
7
7
2023
Statut:
epublish
Résumé
According to crystal engineering, the pharmaceutical intermediate
Identifiants
pubmed: 37416673
doi: 10.1016/j.heliyon.2023.e17494
pii: S2405-8440(23)04702-3
pmc: PMC10320128
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e17494Informations de copyright
© 2023 Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Eur J Pharm Sci. 2016 Oct 10;93:399-404
pubmed: 27568061
J Pharm Sci. 2022 Oct;111(10):2788-2798
pubmed: 35508209
J Phys Chem Lett. 2018 Jul 5;9(13):3667-3672
pubmed: 29920095
Mol Pharm. 2015 May 4;12(5):1615-22
pubmed: 25800383
Pharm Res. 2020 May 11;37(6):93
pubmed: 32394114
Chem Commun (Camb). 2016 Jun 28;52(54):8342-60
pubmed: 27278109
Int J Pharm. 2011 Oct 31;419(1-2):1-11
pubmed: 21827842
Eur J Pharm Sci. 2020 Sep 1;152:105452
pubmed: 32622980
Int Sch Res Notices. 2014 Dec 07;2014:452051
pubmed: 27379272
Expert Opin Drug Deliv. 2013 Feb;10(2):201-13
pubmed: 23256822
Dig Dis Sci. 2021 Nov;66(11):3672-3673
pubmed: 33625612
Spectrochim Acta A Mol Biomol Spectrosc. 2022 Jul 5;275:121172
pubmed: 35366525
Chem Commun (Camb). 2013 Sep 14;49(71):7791-3
pubmed: 23880638
J Pharm Sci. 2014 Nov;103(11):3754-3763
pubmed: 25277273
Chem Commun (Camb). 2016 Jan 14;52(4):640-55
pubmed: 26565650
Chem Commun (Camb). 2017 Nov 14;53(91):12266-12269
pubmed: 29058012
Int J Pharm. 2021 Oct 25;608:121116
pubmed: 34555476
Chem Commun (Camb). 2018 Dec 13;54(100):14047-14060
pubmed: 30488919
Drug Dev Ind Pharm. 2020 Oct;46(10):1559-1568
pubmed: 32799687